Effects of hsa-miR-9-3p and hsa-miR-9-5p on Topoisomerase IIβExpression in Human Leukemia K562 Cells with Acquired Resistance to Etoposide
Author:
Publisher
American Society for Pharmacology & Experimental Therapeutics (ASPET)
Subject
Pharmacology,Molecular Medicine
Reference78 articles.
1. A phase 1 trial of XK469: Toxicity profile of a selective topoisomerase IIβ inhibitor
2. TOP2B: The First Thirty Years
3. TOP2B’s contributions to transcription;Austin;Biochem Soc Trans,2021
4. The dual role of microRNA-9 in gastrointestinal cancers: oncomiR or tumor suppressor?;Bahrami;Biomed Pharmacother,2022
5. Genome-Wide Analysis of miRNA-mRNA Interactions in Marrow Stromal Cells
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Use of CRISPR/Cas9 with Homology-Directed Repair to Gene-Edit Topoisomerase IIβin Human Leukemia K562 Cells: Generation of a Resistance Phenotype;Journal of Pharmacology and Experimental Therapeutics;2024-03-20
2. Targeting TOP2B as a vulnerability in aging and aging-related diseases;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-03
3. Understanding Cancer’s Defense against Topoisomerase-Active Drugs: A Comprehensive Review;Cancers;2024-02-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3